These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 19027852

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR, Jäger N, Funke A, Mürb RK, Khinast JG, Paudel A.
    Int J Pharm; 2018 Dec 20; 553(1-2):408-421. PubMed ID: 30326284
    [Abstract] [Full Text] [Related]

  • 3. Investigation of drug-polymer interaction in solid dispersions by vapour sorption methods.
    Punčochová K, Heng JY, Beránek J, Stěpánek F.
    Int J Pharm; 2014 Jul 20; 469(1):159-67. PubMed ID: 24751346
    [Abstract] [Full Text] [Related]

  • 4. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S, O'Donnell KP, Keen JM, Rickard MA, McGinity JW, Williams RO.
    AAPS PharmSciTech; 2016 Feb 20; 17(1):106-19. PubMed ID: 26335416
    [Abstract] [Full Text] [Related]

  • 5. Structural modifications of polymethacrylates: impact on thermal behavior and release characteristics of glassy solid solutions.
    Claeys B, De Coen R, De Geest BG, de la Rosa VR, Hoogenboom R, Carleer R, Adriaensens P, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2013 Nov 20; 85(3 Pt B):1206-14. PubMed ID: 23485474
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S, Bodmeier R.
    Eur J Pharm Biopharm; 2010 Nov 20; 76(3):486-92. PubMed ID: 20868750
    [Abstract] [Full Text] [Related]

  • 8. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA, Basit AW.
    Eur J Pharm Sci; 2011 Jan 18; 42(1-2):30-6. PubMed ID: 20950685
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN, Vemavarapu C, Lodaya M.
    Int J Pharm; 2007 Jan 10; 328(2):119-29. PubMed ID: 16968659
    [Abstract] [Full Text] [Related]

  • 11. Controlling the Release of Indomethacin from Glass Solutions Layered with a Rate Controlling Membrane Using Fluid-Bed Processing. Part 1: Surface and Cross-Sectional Chemical Analysis.
    Dereymaker A, Scurr DJ, Steer ED, Roberts CJ, Van den Mooter G.
    Mol Pharm; 2017 Apr 03; 14(4):959-973. PubMed ID: 28206770
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
    Sathigari SK, Radhakrishnan VK, Davis VA, Parsons DL, Babu RJ.
    J Pharm Sci; 2012 Sep 03; 101(9):3456-64. PubMed ID: 22437488
    [Abstract] [Full Text] [Related]

  • 14. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J, Koerber M, Walther M, Bodmeier R.
    Int J Pharm; 2014 Jul 20; 469(1):94-101. PubMed ID: 24746409
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pairwise polymer blends for oral drug delivery.
    Marks JA, Wegiel LA, Taylor LS, Edgar KJ.
    J Pharm Sci; 2014 Sep 20; 103(9):2871-2883. PubMed ID: 24823790
    [Abstract] [Full Text] [Related]

  • 17. Stabilisation of amorphous drugs under high humidity using pharmaceutical thin films.
    Ng YC, Yang Z, McAuley WJ, Qi S.
    Eur J Pharm Biopharm; 2013 Aug 20; 84(3):555-65. PubMed ID: 23403014
    [Abstract] [Full Text] [Related]

  • 18. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M, Wu C, Fu Q, Di D, Kuang X, Wang C, He Z, Wang J, Sun J.
    Int J Pharm; 2016 Apr 30; 503(1-2):238-46. PubMed ID: 26869398
    [Abstract] [Full Text] [Related]

  • 19. Crystal growth formation in melt extrudates.
    Bruce C, Fegely KA, Rajabi-Siahboomi AR, McGinity JW.
    Int J Pharm; 2007 Aug 16; 341(1-2):162-72. PubMed ID: 17524578
    [Abstract] [Full Text] [Related]

  • 20. Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation.
    Li G, Han D, Guan T, Zhao X, He H, Tang X.
    Int J Pharm; 2010 Nov 15; 400(1-2):138-44. PubMed ID: 20826202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.